Clinical Trial Update: Impact of a Regional Program Agir Sur Sa SantE

View source ↗

Summary

Clinical trial update on the impact of a regional program called Agir Sur Sa SantE, studying type 2 diabetes, obesity, and related cardiovascular risk factors; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Dyslipidemias
• Hypertension
• Obesity
• Tobacco Use Disorder
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Université de Sherbrooke | Conditions: Diabetes Mellitus, Type 2, Obesity | Status: ACTIVE_NOT_RECRUITING